TISSUE CROSS-REACTIVITY STUDY OF A HUMAN ANTIBODY
$107,538N02FY2021CANIH
Sri International, Menlo Park CA
Investigators
Abstract
The test agent is being considered for development as an anticancer therapeutic. The objective of this task was to obtain a source of tissue or cells for in vitro evaluations of toxicity. The information obtained from this investigation was used to identify drugs with the potential to treat cancer.
View original record on NIH RePORTER →